MississippiVision.com
About MississippiVision.com
The FDA has recently approved a revolutionary lens for the correction of nearsightedness and hi-myopia ranging from -3 to -15 dopters.Learn more about the ICL procedure. With its unique, patented optic design, it allows patients to experience the highest level of freedom from glasses ever achieved in IOL clinical trials. Learn more about the ReSTOR lens.
